Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Cowling

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell Metabolism|January 15, 2013
Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesisHoon-Ki Sung, Kyung-Oh Doh, Joe Eun Son, et al.
Biochemical Society Symposium|November 1, 2003
Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activityRoy A Black, John R Doedens, Rajeev Mahimkar, et al.
Bioorganic & Medicinal Chemistry|October 20, 2009
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3Lisa M Havran, Dan C Chong, Wayne E Childers, et al.
International Immunopharmacology|November 9, 2004
Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzymeYuhua Zhang, Martin Hegen, Jun Xu, et al.
Peptides|April 1, 2006
A novel approach to identifying beta-secretase inhibitors: bis-statine peptide mimetics discovered using structure and spot synthesisKristie Grove Bridges, Rajiv Chopra, Laura Lin, et al.
Journal of Medicinal Chemistry|May 30, 2003
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritisVenkatesan Aranapakam, Jamie M Davis, George T Grosu, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pocketsDerek C Cole, Joseph R Stock, Rajiv Chopra, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitorsPawel Nowak, Derek C Cole, Ann Aulabaugh, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocketLee D Jennings, Derek C Cole, Joseph R Stock, et al.
Journal of Medicinal Chemistry|October 13, 2006
Acylguanidines as small-molecule beta-secretase inhibitorsDerek C Cole, Eric S Manas, Joseph R Stock, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Metabolism|January 15, 2013
Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesisHoon-Ki Sung, Kyung-Oh Doh, Joe Eun Son, et al.
Biochemical Society Symposium|November 1, 2003
Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activityRoy A Black, John R Doedens, Rajeev Mahimkar, et al.
Bioorganic & Medicinal Chemistry|October 20, 2009
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3Lisa M Havran, Dan C Chong, Wayne E Childers, et al.
International Immunopharmacology|November 9, 2004
Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzymeYuhua Zhang, Martin Hegen, Jun Xu, et al.
Peptides|April 1, 2006
A novel approach to identifying beta-secretase inhibitors: bis-statine peptide mimetics discovered using structure and spot synthesisKristie Grove Bridges, Rajiv Chopra, Laura Lin, et al.
Journal of Medicinal Chemistry|May 30, 2003
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritisVenkatesan Aranapakam, Jamie M Davis, George T Grosu, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pocketsDerek C Cole, Joseph R Stock, Rajiv Chopra, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitorsPawel Nowak, Derek C Cole, Ann Aulabaugh, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocketLee D Jennings, Derek C Cole, Joseph R Stock, et al.
Journal of Medicinal Chemistry|October 13, 2006
Acylguanidines as small-molecule beta-secretase inhibitorsDerek C Cole, Eric S Manas, Joseph R Stock, et al.
Pageof 2